MAP kinases and hypoxia in the control of VEGF expression

Cancer and Metastasis Reviews

Volumn 19, Issue 1-2, 2000, Pages 139-145

  Berra, E ^a   Pages, G ^a   Pouyssegur, J ^a  

^a CENTRE DE BIOCHIMIE   (France)

Author keywords

Angiogenesis; Growth control; Hypoxia; MAP kinases; VEGF

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; CONTROL SYSTEM; EMBRYO DEVELOPMENT; ENDOTHELIUM CELL; ENZYME PHOSPHORYLATION; GENE DISRUPTION; GROWTH INHIBITION; HYPOXIA; MESSENGER RNA SYNTHESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; REVIEW; TRANSCRIPTION REGULATION; VASCULAR ENDOTHELIUM;

ANIMALS; CELL HYPOXIA; CELLS, CULTURED; CRICETINAE; DNA-BINDING PROTEINS; ENDOTHELIAL GROWTH FACTORS; GENE EXPRESSION REGULATION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LYMPHOKINES; MAP KINASE SIGNALING SYSTEM; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; NEOVASCULARIZATION, PHYSIOLOGIC; NUCLEAR PROTEINS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034531952     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026506011458     Document Type: Review

References (54)

1. What is the evidence that tumors are angiogenesis dependent?
2. Angiogenesis
3. Angiogenesis in cancer, vascular, rheumatoid and other disease
4. Clinical importance of the determination of tumor angiogenesis in breast carcinoma: Much more than a new prognostic tool
5. Vascular endothelial growth factor is a secreted angiogenic mitogen
6. Mechanisms of angiogenesis
7. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing
8. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors
9. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
10. Heterozygous embryonic lethality induced by targeted inactivation of the VEGE gene
11. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
12. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
13. How MAP kinases are regulated
14. Ras target proteins in eukaryotic cells
15. Mitogen-activated protein kinases p42 MAPK and p44 MAPK are required for fibroblast proliferation
16. Phosphorylation of the cap-binding protein eukaryotic translation initiation factor 4E by protein kinase Mnk1 in vivo
17. Human eukaryotic translation initiation factor 4G (eIF4G) recruits Mnk1 to phosphorylate eIF4E
18. Defective thymocyte maturation in p44 MAP kinase (Erk1) knockout mice
19. Regulation of carbamoyl phosphate synthetase by MAP kinase
20. The p42/p44 MAP kinase pathway prevents apoptosis induced by anchorage and serum removal
21. Conditional transformation of cells and rapid activation of the mitogen-activated protein kinase cascade by an estradiol-dependent human raf-1 protein kinase
22. Oncogenic Raf-1 activates p70 S6 kinase via a mitogen-activated protein kinase-independent pathway
23. Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells
24. Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing
25. Both v-Ha-Ras and v-Raf stimulate expression of the vascular endothelial growth factor in NIH 3T3 cells
26. Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia
27. Transforming growth factor-alpha-induced transcriptional activation of the vascular permeability factor [VPF/VEGF) gene requires AP-2-dependent DNA binding and transactivation
28. Oncogenic transformation and hypoxia synergistically act to modulate vascular endothelial growth factor expression
29. Induction of vascular endothelial growth factor by hypoxia is modulated by a phosphatidylinositol 3-kinase/Akt signaling pathway in Ha-ras-transformed cells through a hypoxia inducible factor-1 transcriptional element
30. Oncogenes and tumor angiogenesis: Differential modes of vascular endothelial growth factor up-regulation in ras-transformed epithelial cells and fibroblasts
31. p42/p44 MAP kinase module plays a key role in the transcriptional regulation of the vascular endothelial growth factor gene in fibroblasts
32. Stress activated protein kinases (c-Jun N terminal Kinase and p38/HOG) are essential for VEGF mRNA stability
33. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia
34. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
35. Purification and characterization of hypoxia-inducible factor 1
36. The hypoxic response: Huffing and HIFing
37. Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit
38. Functional interference between hypoxia and dioxin signal transduction pathways: Competition for recruitment of the Arnt transcription factor
39. Activation of hypoxia-inducible factor 1alpha: Posttranscriptional regulation and conformational change by recruitment of the Arnt transcription factor
40. Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells
41. Angiogenesis: How a tumor adapts to hypoxia
42. Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes
43. 2-dependent degradation domain via the ubiquitin proteasome pathway
44. Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin-proteasome pathway
45. Loss of PTEN facilitates HIF-1-mediated gene expression
46. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
47. Mdm2 promotes the rapid degradation of p53
48. Regulation of p53 stability by Mdm2
49. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
50. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha
51. p42/p44 Mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1alpha (HIF-1alpha) and enhance the transcriptional activity of HIF-1
52. Effect of protein kinase and phosphatase inhibitors on expression of hypoxia-inducible factor 1
53. 2 homeostasis
54. Catalytic activation of the phosphatase MKP-3 by ERK2 mitogen-activated protein kinase